Friday, March 12, 2021 9:20:33 AM
As to what you quote from the filings:
The problem is that there was never any follow on filing indicating the purchase agreement actually came to fruition. But assuming it did come to fruition, then $IMMB holds some number of shares in $ENZC and a note receivable. Stock paid directly to Dimitar or others with Bulgarian names is different than stock that would belong to the shareholders of $IMMB common stock, so it's hard to characterize $IMMB as a dead ticker since it clearly owns something, whether it be IP and 49% interest in Immunotech BG, or a note receivable and $ENZC common stock. Unfortunately, there is an incomplete accounting of this deal if it did, in fact, go through and this is complicated by Harry serving as CEO of $IMMB and CSO of $ENZC at the same time.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM